Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazoles

Paul Ratcliffe, Lynn Abernethy, Nasrin Ansari, Ken Cameron, Tom Clarkson, Maureen Dempster, David Dunn, Anna Marie Easson, Darren Edwards, Katy Everett, Helen Feilden, Koc Kan Ho, Steve Kultgen, Peter Littlewood, John MacLean, Duncan McArthur, Deborah McGregor, Hazel McLuskey, Irina Neagu, Olaf NimzLesley Anne Nisbet, Michael Ohlmeyer, Ronnie Palin, Quynhchi Pham, Yajing Rong, Andrew Roughton, Melanie Sammons, Robert Swanson, Heather Tracey, Glenn Walker

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Systematic optimisation of a poorly soluble lead series of isoxazole-3-carboxamides was conducted. Substitution of the 4-position with specific polar functionality afforded the requisite balance of potency, solubility and physicochemical properties. Compound 21a was found to be efficacious in the rat Capsaicin Hargreaves assay following oral administration.

Original languageEnglish
Pages (from-to)4652-4657
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume21
Issue number15
DOIs
StatePublished - 1 Aug 2011
Externally publishedYes

Keywords

  • Antihyperalgesia
  • Isoxazoles
  • TRPV1 antagonist

Fingerprint

Dive into the research topics of 'Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazoles'. Together they form a unique fingerprint.

Cite this